Skip to content

What's new in the field of lipids, and can it help us prevent stroke?

March 24, 2026 · 10 min

Show notes

In this episode of Voice of Stroke, we explore new evidence shaping how lipid management can reduce stroke risk across both primary and secondary prevention.

This episode explores:

  • Reassessing statin side effects using large-scale randomised trial data
  • The role of PCSK9 inhibition (VESALIUS-CV) in reducing vascular events in high-risk patients without prior stroke
  • Long-term data linking LDL, lipoprotein(a), and inflammation to stroke risk decades later

Together, these findings clarify safety concerns, expand preventive options, and highlight the importance of long-term risk prediction in stroke care.

This episode was written by Linxin Li, Editor-in-Chief of the Voice of Stroke Podcast, and Co-Editor Ahmad Nehme.

Note: Full transcript available here.

The following publications were mentioned in this podcast:

All episodes of ESO Voice of Stroke

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.